Azamulin is a pleuromutilin antibiotic that functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. Beyond its antibacterial properties, it is also utilized in… Read more
Azamulin is a pleuromutilin antibiotic that functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. Beyond its antibacterial properties, it is also utilized in pharmacological research as an inhibitor of the liver enzymes CYP3A4 and CYP3A5. Although it remains unmarketed in many major regions, it is a subject of investigation for its activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. This category provides access to high-quality reference standards of the Azamulin API, as well as specific impurities such as 2’-tosyloxy-dihydropleuromutilin. Analytical chemists use these characterized materials, including pharmacopeial and non-pharmacopeial impurities, to perform rigorous impurity profiling, method validation, and ongoing quality control. Laboratories also rely on these compounds to ensure the accuracy and specificity of assays designed to track the degradation and metabolic behavior of pleuromutilin derivatives in complex matrices.